Finch Therapeutics Group, Inc.·4

Nov 27, 4:54 PM ET

SMISEK JEFFERY A 4

4 · Finch Therapeutics Group, Inc. · Filed Nov 27, 2023

Insider Transaction Report

Form 4
Period: 2023-11-22
Transactions
  • Sale

    Common Stock

    2023-11-22$3.64/sh1,470$5,3516,642 total
Holdings
  • Common Stock

    (indirect: See footnote)
    40,260
  • Common Stock

    (indirect: By Spouse)
    8,112
Footnotes (4)
  • [F1]Represents the weighted-average price of shares sold by the broker on behalf of the Reporting Person. The broker sold, in the aggregate on behalf of such Reporting Person, 1,470 shares in transactions ranging from $3.63 to $3.67 with a weighted-average price of $3.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]Includes shares previously held indirectly by Flight Partners Management LLC ("Flight Partners Capital") and are now held directly. The Reporting Person is the president of Flight Partners Capital.
  • [F3]The securities are held by Flight Partners Capital.
  • [F4]Includes shares previously held indirectly by Flight Partners Capital and are now held by the Reporting Person's spouse.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4